$TCNNF
Trulieve Cannabis Corp.

2021 Q2 Form 10-Q Financial Statement

#000156459021043732 Filed on August 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $215.1M $120.8M
YoY Change 78.13% 108.58%
Cost Of Revenue $70.64M $30.23M
YoY Change 133.65% 211.68%
Gross Profit $144.5M $90.53M
YoY Change 59.59% 87.83%
Gross Profit Margin 67.16% 74.97%
Selling, General & Admin $61.52M $34.95M
YoY Change 76.04% 111.79%
% of Gross Profit 42.58% 38.6%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $7.300M $3.600M
YoY Change 102.78% 44.58%
% of Gross Profit 5.05% 3.98%
Operating Expenses $68.19M $38.05M
YoY Change 79.2% 118.67%
Operating Profit $76.30M $52.48M
YoY Change 45.38% 70.4%
Interest Expense $6.649M $5.302M
YoY Change 25.41% -507.85%
% of Operating Profit 8.71% 10.1%
Other Income/Expense, Net -$6.316M -$10.27M
YoY Change -38.51% 10171.0%
Pretax Income $69.98M $42.21M
YoY Change 65.79% 43.09%
Income Tax $29.10M $23.27M
% Of Pretax Income 41.58% 55.14%
Net Earnings $40.88M $18.94M
YoY Change 115.86% 11.4%
Net Earnings / Revenue 19.0% 15.68%
Basic Earnings Per Share $0.33 $0.17
Diluted Earnings Per Share $0.31 $0.16
COMMON SHARES
Basic Shares Outstanding 125.6M 111.6M
Diluted Shares Outstanding 133.0M 115.3M

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $289.2M $150.3M
YoY Change 92.44% 178.33%
Cash & Equivalents $289.2M $150.3M
Short-Term Investments
Other Short-Term Assets $28.31M $12.20M
YoY Change 132.07% 221.05%
Inventory $112.6M $73.80M
Prepaid Expenses
Receivables $3.754M
Other Receivables $8.157M
Total Short-Term Assets $437.8M $236.3M
YoY Change 85.29% 22.75%
LONG-TERM ASSETS
Property, Plant & Equipment $427.9M $246.3M
YoY Change 73.74% 68.93%
Goodwill $71.12M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $13.79M $3.100M
YoY Change 344.94% 210.0%
Total Long-Term Assets $723.2M $282.0M
YoY Change 156.47% 56.58%
TOTAL ASSETS
Total Short-Term Assets $437.8M $236.3M
Total Long-Term Assets $723.2M $282.0M
Total Assets $1.161B $518.3M
YoY Change 124.02% 39.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $45.58M $21.60M
YoY Change 111.01% 83.05%
Accrued Expenses $3.583M $2.900M
YoY Change 23.55%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $21.39M $17.60M
YoY Change 21.53% -10.2%
Total Short-Term Liabilities $77.45M $107.9M
YoY Change -28.22% 70.73%
LONG-TERM LIABILITIES
Long-Term Debt $250.0M $73.50M
YoY Change 240.09% -27.66%
Other Long-Term Liabilities $4.145M $143.7M
YoY Change -97.12%
Total Long-Term Liabilities $4.145M $217.2M
YoY Change -98.09% 113.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $77.45M $107.9M
Total Long-Term Liabilities $4.145M $217.2M
Total Liabilities $402.8M $329.7M
YoY Change 22.17% 67.36%
SHAREHOLDERS EQUITY
Retained Earnings $190.6M
YoY Change
Common Stock $525.0M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $758.3M $188.6M
YoY Change
Total Liabilities & Shareholders Equity $1.146B $518.3M
YoY Change 121.17% 39.1%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income $40.88M $18.94M
YoY Change 115.86% 11.4%
Depreciation, Depletion And Amortization $7.300M $3.600M
YoY Change 102.78% 44.58%
Cash From Operating Activities -$11.20M $53.75M
YoY Change -120.83% 285.03%
INVESTING ACTIVITIES
Capital Expenditures -$71.31M -$18.02M
YoY Change 295.73% -14.56%
Acquisitions
YoY Change
Other Investing Activities -$12.02M -$600.0K
YoY Change 1903.0% -97.57%
Cash From Investing Activities -$83.33M -$18.62M
YoY Change 347.52% -59.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 221.3M 14.37M
YoY Change 1440.08% -77.97%
NET CHANGE
Cash From Operating Activities -11.20M 53.75M
Cash From Investing Activities -83.33M -18.62M
Cash From Financing Activities 221.3M 14.37M
Net Change In Cash 126.8M 49.50M
YoY Change 156.13% 47.98%
FREE CASH FLOW
Cash From Operating Activities -$11.20M $53.75M
Capital Expenditures -$71.31M -$18.02M
Free Cash Flow $60.11M $71.77M
YoY Change -16.24% 104.76%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2020 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2021Q2 us-gaap Change In Accounting Principle Accounting Standards Update Adopted
ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted
true
CY2021Q2 us-gaap Change In Accounting Principle Accounting Standards Update Immaterial Effect
ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect
true
us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
us-gaap:AccountingStandardsUpdate201912Member
CY2021Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2020Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P8Y10D
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y5M23D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.4910
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0140
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.5015
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0158
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y3D
tcnnf Share Based Compensation Arrangement By Share Based Payment Award Options Grants Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsWeightedAverageRemainingContractualTerm
P4Y6M7D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y9M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y7M2D
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
314045000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
28171000
CY2020Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
36904000
CY2021Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
8157000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
19815000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
265148000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
93800000
CY2020Q4 us-gaap Goodwill
Goodwill
74100000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3944000
CY2020Q4 us-gaap Assets
Assets
816112000
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
41903000
CY2020Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
12011000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3154000
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
3877000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
75998000
CY2020Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
4000000
CY2021Q2 tcnnf Private Placement Notes Liability Net
PrivatePlacementNotesLiabilityNet
118673000
CY2020Q4 tcnnf Private Placement Notes Liability Net
PrivatePlacementNotesLiabilityNet
117165000
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4145000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3915000
CY2021Q2 tcnnf Construction Finance Liability
ConstructionFinanceLiability
90263000
CY2020Q4 tcnnf Construction Finance Liability
ConstructionFinanceLiability
82047000
CY2021Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
29845000
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
23575000
CY2021Q2 us-gaap Liabilities
Liabilities
390072000
CY2020Q4 us-gaap Liabilities
Liabilities
368208000
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
126982700
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
126982700
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
119573998
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
119573998
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
522898000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
275644000
CY2021Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
42689000
CY2020Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
52570000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
190648000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
119690000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
756235000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
447904000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1146307000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
816112000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
215122000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
120765000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
408945000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
216821000
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
70639000
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
30233000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
129198000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
52459000
CY2021Q2 us-gaap Gross Profit
GrossProfit
144483000
CY2020Q2 us-gaap Gross Profit
GrossProfit
90532000
us-gaap Gross Profit
GrossProfit
279747000
us-gaap Gross Profit
GrossProfit
164362000
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14942000
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7936000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6316000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
49873000
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6667000
CY2020Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3104000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
12101000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5298000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
68185000
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
38049000
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10271000
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
27009000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
91135000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
27650000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14195000
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
46576000
us-gaap Operating Expenses
OperatingExpenses
130886000
us-gaap Operating Expenses
OperatingExpenses
69366000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
76298000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
52483000
us-gaap Operating Income Loss
OperatingIncomeLoss
148861000
us-gaap Operating Income Loss
OperatingIncomeLoss
94996000
CY2021Q2 us-gaap Interest Expense
InterestExpense
6649000
CY2020Q2 us-gaap Interest Expense
InterestExpense
5302000
us-gaap Interest Expense
InterestExpense
14548000
us-gaap Interest Expense
InterestExpense
11214000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
333000
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4969000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
295000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-71000
tcnnf Depreciation And Amortization Included In Cost Of Goods Sold
DepreciationAndAmortizationIncludedInCostOfGoodsSold
4891000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
133002231
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115307313
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-14253000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11285000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
69982000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
42212000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
134608000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
83711000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
29102000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23274000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
63650000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
41168000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
40880000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
18938000
us-gaap Net Income Loss
NetIncomeLoss
70958000
us-gaap Net Income Loss
NetIncomeLoss
42543000
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.55
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.37
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
125631725
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
111573332
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
120351366
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
110959839
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
127884913
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114468339
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
447904000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
741000
CY2021Q1 tcnnf Stock Issued During Period Value For Warrants Exercise
StockIssuedDuringPeriodValueForWarrantsExercise
6861000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
30078000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
485584000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
744000
CY2021Q2 tcnnf Stock Issued During Period Value For Warrants Exercise
StockIssuedDuringPeriodValueForWarrantsExercise
811000
CY2021Q2 tcnnf Tax Withholding Related To Net Share Settlement Of Equity Awards
TaxWithholdingRelatedToNetShareSettlementOfEquityAwards
595000
CY2021Q2 tcnnf Issuance Of Shares In Offering Net Of Issuance Costs
IssuanceOfSharesInOfferingNetOfIssuanceCosts
217896000
CY2021Q2 tcnnf Adjustments To Additional Paid In Capital Contingent Consideration Payable In Shares
AdjustmentsToAdditionalPaidInCapitalContingentConsiderationPayableInShares
2800000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
40880000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
756235000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
132883000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1222000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
23605000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
157710000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
462000
CY2020Q2 tcnnf Stock Issued During Period Value For Warrants Exercise
StockIssuedDuringPeriodValueForWarrantsExercise
11458000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
18938000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
188568000
us-gaap Profit Loss
ProfitLoss
70958000
us-gaap Profit Loss
ProfitLoss
42543000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
12101000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5298000
tcnnf Non Cash Interest Income Expense
NonCashInterestIncomeExpense
-1507000
tcnnf Depreciation And Amortization Included In Cost Of Goods Sold
DepreciationAndAmortizationIncludedInCostOfGoodsSold
8687000
us-gaap Proceeds From Construction Loans Payable
ProceedsFromConstructionLoansPayable
18600000
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
217896000
tcnnf Non Cash Interest Income Expense
NonCashInterestIncomeExpense
-1434000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1910000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1508000
us-gaap Share Based Compensation
ShareBasedCompensation
1485000
us-gaap Share Based Compensation
ShareBasedCompensation
1685000
tcnnf Accretion Of Construction Finance Liability
AccretionOfConstructionFinanceLiability
1068000
tcnnf Accretion Of Construction Finance Liability
AccretionOfConstructionFinanceLiability
430000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1021000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1986000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-915000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
14316000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7820000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3446000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
8896000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4539000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
5603000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2196000
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-14032000
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
42838000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2152000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-8666000
tcnnf Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-1633000
tcnnf Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-1233000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-992000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1392000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
230000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
49194000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
77671000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
115302000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
27923000
tcnnf Payments For Purchases Of Property And Equipment Related To Construction Finance Liability
PaymentsForPurchasesOfPropertyAndEquipmentRelatedToConstructionFinanceLiability
7147000
tcnnf Payments For Purchases Of Property And Equipment Related To Construction Finance Liability
PaymentsForPurchasesOfPropertyAndEquipmentRelatedToConstructionFinanceLiability
17694000
us-gaap Payments For Software
PaymentsForSoftware
1951000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
10158000
tcnnf Repayment Of Capitalized Interest
RepaymentOfCapitalizedInterest
2130000
tcnnf Repayment Of Capitalized Interest
RepaymentOfCapitalizedInterest
814000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-136688000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-46431000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
7672000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
11458000
us-gaap Proceeds From Construction Loans Payable
ProceedsFromConstructionLoansPayable
7148000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
2091000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
2056000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
11000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
742000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
595000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
230019000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
27260000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
142525000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
58500000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
146713000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
91813000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
289238000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
150313000
us-gaap Interest Paid Net
InterestPaidNet
15047000
us-gaap Interest Paid Net
InterestPaidNet
10362000
us-gaap Income Taxes Paid
IncomeTaxesPaid
79950000
us-gaap Income Taxes Paid
IncomeTaxesPaid
115000
us-gaap Noncash Or Part Noncash Divestiture Amount Of Consideration Received1
NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
2800000
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
12383000
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
13520000
us-gaap Stock Issued1
StockIssued1
10000000
tcnnf Purchase Of Property And Equipment Financed With Accounts Payable
PurchaseOfPropertyAndEquipmentFinancedWithAccountsPayable
13751000
tcnnf Purchase Of Property And Equipment Financed With Accounts Payable
PurchaseOfPropertyAndEquipmentFinancedWithAccountsPayable
5919000
us-gaap Nature Of Operations
NatureOfOperations
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">NOTE 1.  THE COMPANY</p> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Trulieve Cannabis Corp. (together with its subsidiaries, “Trulieve” or the “Company”) was incorporated in British Columbia, Canada. Trulieve (through its wholly-owned subsidiaries) is a vertically integrated cannabis company which currently holds licenses to operate in six states Florida, Massachusetts, California, Connecticut, Pennsylvania and West Virginia, to cultivate, produce, and sell medicinal-use cannabis products and, with respect to California and Massachusetts, adult-use cannabis products. All revenues are generated in the United States, and all long-lived assets are located in the United States. </span><span style="color:#000000;">As of June 30, 2021, substantially all of our revenue was generated from the sale of medical cannabis products in the State of Florida. To date, neither the sale of adult-use cannabis products, nor our operations in Massachusetts, California, Connecticut, Pennsylvania, and West Virginia, have been material to our business.</span></p> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In July 2018, Trulieve, Inc. entered into a non-binding letter agreement (“Letter Agreement”) with Schyan Exploration Inc. (“Schyan”) whereby Trulieve, Inc. and Schyan have agreed to merge their respective businesses resulting in a reverse takeover of Schyan by Trulieve, Inc. and change the business of Schyan from a mining issuer to a marijuana issuer (the “Transaction”). The Transaction was completed in August 2018 and Schyan changed its name to Trulieve Cannabis Corp. </span></p> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The Company’s head office is located Tallahassee, Florida. The Company’s registered office is located in British Columbia.</span></p> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The Company is listed on the Canadian Securities Exchange (the “CSE”) and began trading on September 24, 2018 under the ticker symbol “TRUL”, and trades on the OTCQX market under the symbol “TCNNF”. </span></p>
us-gaap Basis Of Accounting
BasisOfAccounting
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">NOTE </span><span style="color:#000000;">2.  BASIS OF PRESENTATION</span></p> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and the rules and regulations of the Securities and Exchange Commission (the “SEC”). </p> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying unaudited condensed consolidated financial statements contain all normal and recurring adjustments necessary to state fairly the consolidated financial condition, results of operations, comprehensive income, statement of shareholders’ equity, and cash flows of the Company for the interim periods presented.  Except as otherwise disclosed, all such adjustments consist only of those of a normal recurring nature.  Operating results for the six months ended June 30, 2021 are not necessarily indicative of the results that may be expected for the current year ending December 31, 2021. The financial data presented herein should be read in conjunction with the audited consolidated financial statements and accompanying notes as of and for the years ended December 31, 2020 and 2019 (“2020 audited consolidated financial statements”).</p> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of these unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods.  Actual results could differ materially from those estimates. </p> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to the rules and regulations of the SEC and the instructions to Form 10-Q.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Reclassifications</p> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain prior period amounts have been reclassified to conform to the current period presentation and include:</p> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:3.33%;white-space:nowrap" valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"> </p></td> <td style="width:3.33%;white-space:nowrap" valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">•</span></p></td> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">Reclassification of internal use software with a net book value of $3.7 million from “Property and equipment, net” to “Intangible assets, net” in the consolidated balance sheet as of December 31, 2020, due to a change in accounting policy. </span></p></td></tr></table></div> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:3.33%;white-space:nowrap" valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"> </p></td> <td style="width:3.33%;white-space:nowrap" valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">•</span></p></td> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">Reclassification of property and equipment with a net book value of $50.0 million from construction in progress to land, buildings and improvements, and furniture and equipment in Footnote 5, Property and Equipment as of December 31, 2020.</span></p></td></tr></table></div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Significant Accounting Policies</p> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s significant accounting policies are described in Note 2 to the Company’s consolidated financial statements included in the 2020 Form 10-K.  There have been no material changes to the Company’s significant accounting policies, except for the adoption of ASU 2019-12 as explained below. </p> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> In December 2019, the FASB issued ASU 2019-12,<span style="font-style:italic;"> Income Taxes (Topic 740) – Simplifying the Accounting for Income Taxes</span>, which is intended to simplify various aspects related to accounting for income taxes.  ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application.  The Company adopted ASU 2019-12 on January 1, 2021 and the adoption did not have a material impact on the Company’s consolidated financial statements. </p> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">COVID-19 Pandemic</span></p> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The global outbreak of the novel strain of the coronavirus known as COVID-19 has resulted in governments worldwide enacting emergency measures to combat the spread of the virus. </span></p> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In response to the outbreak, governmental authorities in the United States, Canada and internationally have introduced various recommendations and measures to try to limit the pandemic, including travel restrictions, border closures, non-essential business closures, quarantines, self-isolations, shelters-in-place and social distancing. Management has been closely monitoring the impact of COVID-19, with a focus in the health and safety of the Company’s employees, business continuity and supporting its communities. The Company has enacted various measures to reduce the spread of the virus, including implementing social distancing at its cultivation facilities and dispensaries, enhancing cleaning protocols at such facilities and dispensaries and encouraging employees to adhere to preventative measures recommended by local, state, and federal health officials.  </span></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p>
CY2021Q2 us-gaap Change In Accounting Principle Accounting Standards Update Adoption Date
ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate
2021-01-01
CY2021Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
34670000
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
21894000
CY2021Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
56822000
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
54780000
CY2021Q2 us-gaap Inventory Net
InventoryNet
112628000
CY2020Q4 us-gaap Inventory Net
InventoryNet
98312000
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
470441000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
343903000
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
42775000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
29858000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
427666000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
314045000
CY2021Q2 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
1800000
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
2100000
CY2020Q2 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
600000
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
800000
CY2021Q2 us-gaap Depreciation
Depreciation
7300000
us-gaap Depreciation
Depreciation
12900000
CY2020Q2 us-gaap Depreciation
Depreciation
3600000
us-gaap Depreciation
Depreciation
6800000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
93800000
us-gaap Finite Lived Intangible Assets Purchase Accounting Adjustments
FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments
3683000
us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
30147000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4524000
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
123106000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
30036000
CY2020 tcnnf Finite Lived Intangible Assets Acquired License Agreements
FiniteLivedIntangibleAssetsAcquiredLicenseAgreements
887000
CY2020 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
65870000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2993000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
93800000
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2500000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4500000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
5359000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
11134000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
10348000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
9376000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
8923000
CY2021Q2 tcnnf Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
77966000
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
123106000
CY2019Q4 us-gaap Goodwill
Goodwill
7316000
CY2020Q4 us-gaap Goodwill
Goodwill
74100000
CY2021Q2 us-gaap Goodwill
Goodwill
71123000
CY2021Q2 us-gaap Notes Payable
NotesPayable
6000000
CY2020Q4 us-gaap Notes Payable
NotesPayable
6000000
CY2021Q2 us-gaap Notes Payable Current
NotesPayableCurrent
4667000
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2000000
CY2021Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
1333000
CY2020Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
4000000
CY2021Q2 tcnnf Notes Payable Maturity Remainder Of Fiscal Year
NotesPayableMaturityRemainderOfFiscalYear
2000000
CY2021Q2 tcnnf Notes Payable Maturing In Next Twelve Months
NotesPayableMaturingInNextTwelveMonths
4000000
CY2021Q2 us-gaap Notes Payable
NotesPayable
6000000
CY2021Q2 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
12000000
CY2020Q4 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
12011000
CY2021Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
12000000
CY2020Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
12011000
CY2021Q2 tcnnf Notes Payable Related Parties Maturities In Next Twelve Months
NotesPayableRelatedPartiesMaturitiesInNextTwelveMonths
12000000
CY2021Q2 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
12000000
CY2021Q1 tcnnf Number Of Unsecured Promissory Notes
NumberOfUnsecuredPromissoryNotes
2
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
130000000
CY2021Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
130000000
CY2021Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
11327000
CY2021Q2 us-gaap Long Term Debt
LongTermDebt
118673000
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1695000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3141000
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1548000
us-gaap Operating Lease Cost
OperatingLeaseCost
3267000
us-gaap Operating Lease Cost
OperatingLeaseCost
2543000
CY2021Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1797000
CY2020Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1336000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
3367000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
2192000
CY2021Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
958000
CY2020Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
612000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1737000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1019000
CY2021Q2 tcnnf Finance Lease Cost
FinanceLeaseCost
2755000
CY2020Q2 tcnnf Finance Lease Cost
FinanceLeaseCost
1948000
tcnnf Finance Lease Cost
FinanceLeaseCost
5104000
tcnnf Finance Lease Cost
FinanceLeaseCost
3211000
CY2021Q2 us-gaap Variable Lease Cost
VariableLeaseCost
215000
CY2020Q2 us-gaap Variable Lease Cost
VariableLeaseCost
189000
us-gaap Variable Lease Cost
VariableLeaseCost
610000
us-gaap Variable Lease Cost
VariableLeaseCost
282000
CY2021Q2 us-gaap Lease Cost
LeaseCost
4665000
CY2020Q2 us-gaap Lease Cost
LeaseCost
3685000
us-gaap Lease Cost
LeaseCost
8981000
us-gaap Lease Cost
LeaseCost
6036000
CY2021Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0836
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0866
CY2021Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
4117000
CY2021Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
8086000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6191000
CY2021Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
7691000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
6005000
CY2021Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
7188000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
5644000
CY2021Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
6821000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
5597000
CY2021Q2 tcnnf Finance Lease Liability Payments Due After Year Four
FinanceLeaseLiabilityPaymentsDueAfterYearFour
28166000
CY2021Q2 tcnnf Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
18577000
CY2021Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
62069000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
45155000
CY2021Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
17652000
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
12191000
CY2021Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
44417000
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
32964000
CY2021Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
4723000
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3583000
CY2021Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
39694000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
29381000
CY2021Q2 us-gaap Share Price
SharePrice
33.42
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
33.42
CY2021Q2 tcnnf Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Fair Value At Grant Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValueAtGrantDate
11.20
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.4988
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0016
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1500000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1129774
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.72
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
326872
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
33.42
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1456646
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.59
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
20910
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
554459
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
11.70
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
25800
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y3D
CY2018Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
8784872
CY2018Q4 tcnnf Class Of Warrant Or Right Vesting
ClassOfWarrantOrRightVesting
0
CY2018 tcnnf Class Of Warrant Or Right Exercisable Term
ClassOfWarrantOrRightExercisableTerm
P3Y
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15000000.0
CY2021Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
3200000
us-gaap Class Of Warrant Or Right Reason For Issuing To Nonemployees
ClassOfWarrantOrRightReasonForIssuingToNonemployees
(i) the warrants may not be exercised for 18 months following the Issue Date; (ii) 50% of the warrants may be exercised between months 19-24 following the Issue Date; and (iii) the remaining 50% of the warrants may be exercised at any time thereafter until expiration.
CY2018 tcnnf Class Of Warrant Or Right May Not Be Exercised Term
ClassOfWarrantOrRightMayNotBeExercisedTerm
P18M
tcnnf Warrants Related To Share Based Compensation Issued
WarrantsRelatedToShareBasedCompensationIssued
0
tcnnf Warrants Related To Share Based Compensation Issued
WarrantsRelatedToShareBasedCompensationIssued
0
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
40880000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
18938000
us-gaap Net Income Loss
NetIncomeLoss
70958000
us-gaap Net Income Loss
NetIncomeLoss
42543000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
125631725
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
111573332
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
120351366
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
110959839
CY2021Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
7370506
CY2020Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
3733981
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
7533547
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
3508500
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
133002231
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115307313
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
127884913
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114468339
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.55
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.37
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
69982000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
42212000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
134608000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
83711000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
29102000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23274000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
63650000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
41168000
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.42
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.55
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.47
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.49
CY2021Q2 us-gaap Notes Receivable Related Parties
NotesReceivableRelatedParties
12000000.0
CY2020Q4 us-gaap Notes Receivable Related Parties
NotesReceivableRelatedParties
12000000.0
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
76400000
CY2020 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
35900000

Files In Submission

Name View Source Status
0001564590-21-043732-index-headers.html Edgar Link pending
0001564590-21-043732-index.html Edgar Link pending
0001564590-21-043732.txt Edgar Link pending
0001564590-21-043732-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gcrgpwtqime3000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tcnnf-10q_20210630.htm Edgar Link pending
tcnnf-10q_20210630_htm.xml Edgar Link completed
tcnnf-20210630.xsd Edgar Link pending
tcnnf-20210630_cal.xml Edgar Link unprocessable
tcnnf-20210630_def.xml Edgar Link unprocessable
tcnnf-20210630_lab.xml Edgar Link unprocessable
tcnnf-20210630_pre.xml Edgar Link unprocessable
tcnnf-ex101_131.htm Edgar Link pending
tcnnf-ex102_132.htm Edgar Link pending
tcnnf-ex311_7.htm Edgar Link pending
tcnnf-ex312_11.htm Edgar Link pending
tcnnf-ex321_8.htm Edgar Link pending